/
JDAssociateChancellorFDA Inspections JDAssociateChancellorFDA Inspections

JDAssociateChancellorFDA Inspections - PDF document

paige
paige . @paige
Follow
343 views
Uploaded On 2021-08-19

JDAssociateChancellorFDA Inspections - PPT Presentation

OverviewFDAsBioresearchMonitoringProgramPreparationforResponseExamplesViolationsOverviewFDAsProgramProgramsprotectrightssafetywelfareinvolvedFDAregulatedclinicalverifyaccuracyreliabilityclinicaldatasu ID: 866908

fda program gov receipt program fda receipt gov downloads regulatoryinformation protocol fdametricsfy www overviewfda fdainvestigatorevaluate

Share:

Link:

Embed:

Download Presentation from below link

Download Pdf The PPT/PDF document "JDAssociateChancellorFDA Inspections" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

1 J.D.AssociateChancellor,FDA Inspections:
J.D.AssociateChancellor,FDA Inspections: OverviewFDA’sBioresearchMonitoringProgramPreparationforResponseExamplesViolations OverviewFDA’sPr

2 ogram Program’sprotectrights,safety,welf
ogram Program’sprotectrights,safety,welfareinvolvedFDAregulatedclinicalverifyaccuracyreliabilityclinicaldatasubmittedFDAresearchmarketingapp

3 lications;complianceFDA'sregulationsgove
lications;complianceFDA'sregulationsgoverningconductclinical Program’sFocus*mayroutine“forcause”.verifyingaccuracyreliabilitydata,mayconduct

4 ed:resultcomplaintconcernterminationclin
ed:resultcomplaintconcernterminationclinicalsiteproviderealassessmentongoingrequestFDAreviewPerFDA’sworkfortargetedhttp://www.fda.gov/downlo

5 ads/RegulatoryInformation/Guidances/UCM1
ads/RegulatoryInformation/Guidances/UCM126 likelihoodmayincreaseEnrollmentlastProtocolviolationsAdverseEventsdeathsstudiessite/PI (FDAMetric

6 sFY’14) Preparationfor WhatBeforeStartCo
sFY’14) Preparationfor WhatBeforeStartContactFDA,notifydesignatedresearchadministrationofficeKUMCRIKUCC,sponsor.FDAChecklist.FDAinvestigator

7 expectrecordsavailableorganized.Identify
expectrecordsavailableorganized.Identifyappropriateroomcopier WhatBeforeStartDeterminedesignatedescort.personkeepquestionsaskeddocumentsrequ

8 ested.availablethroughout.Determineprese
ested.availablethroughout.Determinepresentstartmeeting.arrival,FDAinvestigatorpresentFormFDA Conduct answeringquestions:clear,concise,polite

9 honestvolunteerinformationyouanswer,writ
honestvolunteerinformationyouanswer,writequestionreferquestionappropriateargueFDAInvestigator FDAInvestigatorReview:Regulatorydocuments,prot

10 ocol,enrollmentDatesapprovals,screening,
ocol,enrollmentDatesapprovals,screening,consenting,firstadministrationinvestigationalproduct,etc.CRF’ssourcedocumentationConsentformsIntervi

11 ewstaff FDAinvestigatorConfirm:Whetherre
ewstaff FDAinvestigatorConfirm:Whetherreviewwasobtained(protocol,ICF’s,amendments)WherestudywereperformedWhetherinclusion/exclusioncriteriaw

12 eremetWhetherinformedconsentwasobtainedp
eremetWhetherinformedconsentwasobtainedperformancestudyrelatedprocedures FDAInvestigatorEvaluate:Whetherprotocolwasfollowedwhetherprotocolde

13 viationsweredocumentedreportedWhethercon
viationsweredocumentedreportedWhetherconductstudywasdelegatednatureclinicalinvestigatoroversightWhetheradverseexperienceswereproperlyreporte

14 d FDAInvestigatorEvaluate:Whethersourced
d FDAInvestigatorEvaluate:WhethersourcedocumentationmatchesCRFs,(whereapplicable)whetherdatasubmittedmatchesCRF’s/sourcedocumentsWhetherdocu

15 mentationinvestigationalproductaccountab
mentationinvestigationalproductaccountabilitycomplete(receipt,storage,return) FDAInvestigatorconductexitinterviewdeficienciesarefound,writte

16 nFormFDADocumentobservations,comments,et
nFormFDADocumentobservations,comments,etc.Determinedesignatedresearchadministrationofficepresentforexitinterview.designatedHRPP/Officecontac

17 t. Response ResponseFormFDADeficiencies/
t. Response ResponseFormFDADeficiencies/deviationsfromregulationsareidentifiedFormFDAFormFDAmustprovidedHRPP.writtenresponserequired,encoura

18 ged.ContactOfficeforbestpracticeinformat
ged.ContactOfficeforbestpracticeinformation.Generally, EstablishmentReportEstablishmentReportsent,collectedmaterialsinvestigator’sresponseFD

19 ACenterforevaluationclassification:indic
ACenterforevaluationclassification:indicatedVoluntaryIndicated(VAI)OfficialIndicated(OAI) FDALetterClinicalInvestigatorAfterreviewclassifica

20 tionlettersentclinicalinvestigator.  Â
tionlettersentclinicalinvestigator.   couldletterobservingcompliancepertinentregulationsInformationalUntitledLetterWarningLetterInitiatio

21 nDisqualificationProceedings Classificat
nDisqualificationProceedings Classifications(FDAMetricsFY’14) ExamplesViolations ExamplesViolationsconsentdocumentsrequiredelementsobtaining

22 consentRecordsfailureappropriatelydelega
consentRecordsfailureappropriatelydelegatepersonnel(e.g.,physicalexams,SAEevaluations),resultingexposureunreasonablesignificantinjury,unreli

23 abilitydata ExamplesViolationsCRFsforstu
abilitydata ExamplesViolationsCRFsforstudyexistparticipatestudyFalsifiedconsents(signaturesmatch)CRFsresultsprotocolrequiredproceduresdocume

24 ntationthattheywereand/orresultscharacte
ntationthattheywereand/orresultscharacterizedfromthatwere ExamplesViolationsEnrollingmeetentrancecriteriaAdministrationtestpersonsauthorized

25 receiveFailureperformprotocolrequiredpro
receiveFailureperformprotocolrequiredproceduresdocumentationrequiredreviewstudychanges ExamplesViolationsdocumentationcontinuingreviewIncomp

26 leterecords,e.g.,evidencerecordsdiscarde
leterecords,e.g.,evidencerecordsdiscardeddestroyedinvestigationalproductunauthorizedinadequaterecordsre:receipt,preparation,returninvestigat

27 ionalproduct MostDeficienciesFailurefoll
ionalproduct MostDeficienciesFailurefollowinvestigationaland/orregulationsProtocoldeviationsInadequaterecordkeepingInadequateaccountabilityf

28 orinvestigationalproductInadequatecommun
orinvestigationalproductInadequatecommunicationInadequateprotection—failurereportinformedconsent FDAClinicalInvestigators,U.S.Dept.Servicesh

29 ttp://www.fda.gov/downloads/RegulatoryIn
ttp://www.fda.gov/downloads/RegulatoryInformation/Guid FDAProgramClinicalInvestigatorsInvestigators,ProgramForinvestigators,FDAProgramSponso

30 rs,ContractResearchOrganizationsMonitors
rs,ContractResearchOrganizationsMonitors,Program(MarchforClinicalPractice KUMCResourcesKUMCResearchInstituteCenterKUMCChecklistKUMCResearchP